Liver function and drug processing: a new study on BPN14770
NCT ID NCT07018492
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 26 times
Summary
This study looked at how the drug BPN14770 is handled by the body in people with different levels of liver impairment (mild, moderate, severe) compared to healthy volunteers. A total of 32 adults took a single dose of the drug. The main goal was to measure drug levels in the blood and check for side effects. This is an early-phase study to gather important safety and dosing information.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATIC IMPAIRMENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Division of Clinical Pharmacology, University of Miami
Miami, Florida, 33136, United States
-
Orlando Clinical Research Center
Orlando, Florida, 32809, United States
-
Texas Liver Institute
San Antonio, Texas, 78215, United States
Conditions
Explore the condition pages connected to this study.